Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...
AZ booked $540 million from Enhertu in the fourth quarter, a rise of 54%, and $1.99 billion for the full year out of total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback